Fabricación biofarmacéutica

 
 
Solicitar información

Simplificar la complejidad


El rendimiento fiable y uniforme es la clave para el desarrollo y la fabricación satisfactorios de medicamentos, y esto significa elegir un socio que entienda sus objetivos y pueda suministrarle todo lo que usted necesita de una única fuente probada. Con productos de confianza, experiencia profunda y servicio sin igual de asesoramiento regulatorio, podemos ayudarle a mejorar la uniformidad de sus productos y a comercializarlos más deprisa.

Nuestras herramientas de desarrollo a pequeña escala, fungibles, equipos y sistemas de acero inoxidable o de un solo uso, tecnologías integradas, aplicaciones, validación de procesos y cualificación de equipos, así como nuestros servicios de desarrollo de procesos le ayudarán desde el escalado hasta la producción a escala completa. Y nuestros servicios de producción BPF pueden suministrarle medicamentos BPF con rapidez y eficiencia.

Trabajamos para reducir al mínimo la complejidad, mejorar la productividad, reducir el riesgo y el coste, y dar confianza a los fabricantes farmacéuticos, asegurando así en conjunto la calidad, la biodisponibilidad y la seguridad de los medicamentos que mejoran la vida lanzados al mercado.

Nuevas notas de prensa

18-abr-2018
Merck Wins INTERPHEX Exhibitor Award for Best Technological Innovation

Merck today announced that its Millistak+® HC Pro portfolio has won an INTERPHEX Exhibitor Award for Best Technological Innovation.

20180418 Medicamentos de molécula pequeña,Fabricación biofarmcéutica
17-abr-2018
Merck Introduces New Single-use Technologies to Advance Flexible Manufacturing

Merck today introduced three new products to support flexible manufacturing of biologics.

20180417
12-abr-2018
Merck Helps Accelerate Global Access to Affordable Vaccines

Merck today announced a partnership with Oxford University’s Jenner Institute to develop more robust and scalable vaccine manufacturing processes.

20180412 Medicamentos de molécula pequeña,Fabricación biofarmcéutica
28-mar-2018
Merck Named Best Bioprocessing Supplier in Asia

Merck was named the overall “Best Bioprocessing Supplier” and won the sub-category of “Best Bioprocessing Supplier Award for Single-use Systems” at the Asia-Pacific Bioprocessing Excellence Awards 2018 ceremony.

20180328 Medicamentos de molécula pequeña,Fabricación biofarmcéutica
05-mar-2018
Merck and Schneider Electric Sign MoU to Advance China’s Biopharmaceutical Industry

Merck and Schneider Electric, a global specialist in energy management and automation, today announced the signing of a Memorandum of Understanding (MoU) that aims to automate the mAb process for China’s biopharmaceutical industry.

20180305 Medicamentos de molécula pequeña,Fabricación biofarmcéutica
27-feb-2018
Merck Announces €300,000 in Grants to Accelerate Therapeutic Research in Life Science

Merck today announced the recipients of its Emerging Biotech Grant Program in China.

20180227 Medicamentos de molécula pequeña,Fabricación biofarmcéutica
26-feb-2018
MilliporeSigma Announces 2018 North American Curiosity Cube™ Mobile Science Lab Tour

MilliporeSigma today announced plans for its second annual Curiosity Cube™ mobile science lab tour, which will kick off in February and visit more than 100 communities in the U.S. and Canada.

20180226 Medicamentos de molécula pequeña,Fabricación biofarmcéutica
22-feb-2018
Merck Announces Investment in India with New Life Science Manufacturing & Distribution Centre

Merck today announced that it will invest €16.6 million in its new manufacturing and distribution centre for the Life Science business, located near Mumbai, India.

20180222 Medicamentos de molécula pequeña,Fabricación biofarmcéutica
22-feb-2018
Merck Signs Agreement with Incheon Free Economic Zone to Build Cell Culture Facility in South Korea

Merck today announced it has signed an agreement with Incheon Free Economic Zone (IFEZ) to build an integrated cell culture facility in Songdo, Incheon.

20180222 Medicamentos de molécula pequeña,Fabricación biofarmcéutica
22-feb-2018
Merck Accelerates Mobius® Single-Use Manufacturing in Wuxi

Merck today announced an additional investment to accelerate Mobius® single-use manufacturing in Wuxi, China.

20180222 Medicamentos de molécula pequeña,Fabricación biofarmcéutica
20-feb-2018
Merck Receives Two More Patents for CRISPR Technology

Merck today announced that the Korean Intellectual Property Office and the Israel Patent Office have each issued notices granting Merck’s patent applications for the company’s CRISPR technology.

20180220 Medicamentos de molécula pequeña,Fabricación biofarmcéutica
13-feb-2018
Merck Launches Viresolve® Barrier Capsule Filters to Protect Against Bioreactor Contamination

Merck today introduced Viresolve® Barrier capsule filters to reduce the risk of bioreactor contamination.

20180213 Medicamentos de molécula pequeña,Fabricación biofarmcéutica
Ver todas las novedades
 
Driving Value in the Evolution Toward Continuous Monoclonal Antibody Processing

Upcoming live webinar!
Driving Value in the Evolution Toward Continuous Monoclonal Antibody Processing

June 7, 2018

Register Now
Next Generation Bioprocessing Supplement

New Ebook:
Next Generation Bioprocessing

Download Here
Webinar: Smart Labels - Digital Innovation by Raw Material Suppliers to Support Drug Manufacturers’ Processes

Webinar:
Smart Labels – Digital Innovation by Raw Material Suppliers to Support Drug Manufacturers’ Processes

Watch Now
Explore, Learn, Collaborate: M Lab® Collaboration Centers - Take a tour!
Webinar: Identifying Appropriate-Quality Pharmaceutical Raw Materials in an Evolving Regulatory Environment

Webinar:
Identifying Appropriate-Quality Pharmaceutical Raw Materials in an Evolving Regulatory Environment

Watch Now

Eventos